Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1990 1
1991 1
1992 1
1993 1
1994 3
1998 1
2002 1
2003 1
2004 1
2020 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

14 results
Results by year
Filters applied: . Clear all
Page 1
Discovery, Function, and Therapeutic Targeting of Siglec-8.
Youngblood BA, Leung J, Falahati R, Williams J, Schanin J, Brock EC, Singh B, Chang AT, O'Sullivan JA, Schleimer RP, Tomasevic N, Bebbington CR, Bochner BS. Youngblood BA, et al. Among authors: bebbington cr. Cells. 2020 Dec 24;10(1):19. doi: 10.3390/cells10010019. Cells. 2020. PMID: 33374255 Free PMC article. Review.
Amplification using CHO cell expression vectors.
Kingston RE, Kaufman RJ, Bebbington CR, Rolfe MR. Kingston RE, et al. Among authors: bebbington cr. Curr Protoc Mol Biol. 2002 Nov;Chapter 16:Unit 16.23. doi: 10.1002/0471142727.mb1623s60. Curr Protoc Mol Biol. 2002. PMID: 18265304
CD10 is a key enzyme involved in the activation of tumor-activated peptide prodrug CPI-0004Na and novel analogues: implications for the design of novel peptide prodrugs for the therapy of CD10+ tumors.
Pan C, Cardarelli PM, Nieder MH, Pickford LB, Gangwar S, King DJ, Yarranton GT, Buckman D, Roscoe W, Zhou F, Salles A, Chen TH, Horgan K, Wang YH, Nguyen T, Bebbington CR. Pan C, et al. Among authors: bebbington cr. Cancer Res. 2003 Sep 1;63(17):5526-31. Cancer Res. 2003. PMID: 14500390
14 results